These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 31419102)
1. Cost of dementia in Medicare managed care: a systematic literature review. Fishman P; Coe NB; White L; Crane PK; Park S; Ingraham B; Larson EB Am J Manag Care; 2019 Aug; 25(8):e247-e253. PubMed ID: 31419102 [TBL] [Abstract][Full Text] [Related]
2. Health Care Costs of Alzheimer's and Related Dementias Within a Medicare Managed Care Provider. Fishman PA; White L; Ingraham B; Park S; Larson EB; Crane P; Coe NB Med Care; 2020 Sep; 58(9):833-841. PubMed ID: 32826748 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407 [TBL] [Abstract][Full Text] [Related]
4. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis. Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430 [TBL] [Abstract][Full Text] [Related]
5. Dementia and Medicare at life's end. Lamb VL; Sloan FA; Nathan AS Health Serv Res; 2008 Apr; 43(2):714-32. PubMed ID: 18370975 [TBL] [Abstract][Full Text] [Related]
6. Differences in Medicare Utilization and Expenditures in the Last Six Months of Life among Patients with and without Alzheimer's Disease and Related Disorders. Crouch E; Probst JC; Bennett K; Eberth JM J Palliat Med; 2019 Feb; 22(2):126-131. PubMed ID: 30328762 [TBL] [Abstract][Full Text] [Related]
7. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias. Lin PJ; Biddle AK; Ganguly R; Kaufer DI; Maciejewski ML Med Care; 2009 Nov; 47(11):1174-9. PubMed ID: 19786913 [TBL] [Abstract][Full Text] [Related]
8. Direct medical expenditures associated with Alzheimer's and related dementias (ADRD) in a nationally representative sample of older adults - an excess cost approach. Deb A; Sambamoorthi U; Thornton JD; Schreurs B; Innes K Aging Ment Health; 2018 May; 22(5):619-624. PubMed ID: 28282733 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. Weiner M; Powe NR; Weller WE; Shaffer TJ; Anderson GF J Am Geriatr Soc; 1998 Jun; 46(6):762-70. PubMed ID: 9625195 [TBL] [Abstract][Full Text] [Related]
10. Cost of Alzheimer's disease and related dementia in managed-medicare. Gutterman EM; Markowitz JS; Lewis B; Fillit H J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247 [TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes and healthcare expenditures among patients with dementia undergoing major surgery. Khalil M; Woldesenbet S; Munir MM; Katayama E; Mehdi Khan MM; Altaf A; Rashid Z; Endo Y; Dillhoff M; Tsai S; Pawlik TM World J Surg; 2024 May; 48(5):1075-1083. PubMed ID: 38436547 [TBL] [Abstract][Full Text] [Related]
12. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States. Deb A; Thornton JD; Sambamoorthi U; Innes K Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177 [TBL] [Abstract][Full Text] [Related]
14. The costs of caring: medical costs of Alzheimer's disease and the managed care environment. Murman DL J Geriatr Psychiatry Neurol; 2001; 14(4):168-78. PubMed ID: 11794445 [TBL] [Abstract][Full Text] [Related]
15. One-year Medicare costs associated with delirium in older hospitalized patients with and without Alzheimer's disease dementia and related disorders. Hshieh TT; Gou RY; Jones RN; Leslie DL; Marcantonio ER; Xu G; Travison TG; Fong TG; Schmitt EM; Inouye SK; Alzheimers Dement; 2023 May; 19(5):1901-1912. PubMed ID: 36354163 [TBL] [Abstract][Full Text] [Related]
16. Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States. Frech FH; Li G; Juday T; Ding Y; Mattke S; Khachaturian A; Rosenberg AS; Ndiba-Markey C; Rava A; Batrla R; De Santi S; Hampel H J Prev Alzheimers Dis; 2024; 11(4):983-991. PubMed ID: 39044509 [TBL] [Abstract][Full Text] [Related]
17. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study. Lu S; Hill J; Fillit H Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386 [TBL] [Abstract][Full Text] [Related]
18. The consequences of paying Medicare managed care plans their costs. Sing M; Brown R; Hill SC Inquiry; 1998; 35(2):210-22. PubMed ID: 9719788 [TBL] [Abstract][Full Text] [Related]
19. The effect of donepezil therapy on health costs in a Medicare managed care plan. Hill JW; Futterman R; Mastey V; Fillit H Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682 [TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias. Downer B; Al Snih S; Raji M; Chou LN; Kuo YF; Markides KS; Ottenbacher KJ PLoS One; 2020; 15(1):e0227681. PubMed ID: 31940401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]